Qualigen Therapeutics
Carlsbad, California, United States · Biotechnology, Health Care, Therapeutics
Qualigen Therapeutics, Inc. is a small-cap company facing challenges, including the need to regain compliance with NASDAQ's continued listing requirements. The company aims to establish a new strategic direction and enhance shareholder value.
Key facts
- Headquarters
- Carlsbad, California, United States
- Employees
- 32
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Private
- Website
- qlgntx.com
- Company page
Recent activity at Qualigen Therapeutics
- : Qualigen Therapeutics, Inc. Appoints Koti Meka as Executive Director
- : Qualigen Therapeutics Inc. is rebranding as AIxCrypto and launching the BesTrade DeAI Agent, aimed at optimizing trading transactions.
- : Qualigen Therapeutics Appoints Jerry Wang as Co-CEO and Koti Meka as CFO
- : Qualigen Therapeutics
- : Qualigen Therapeutics
Qualigen Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Aug 2025 | Seed | $4.5M |
| Nov 2024 | Venture | $5.1M |
Leadership
- Kevin Richardson, Interim Ceo/cfo & Board Member
- Jon Cady, National Sales Director
- Steve Lovett, Global Sales Director
- Amelia Sweeney, Accountant
- Koti Meka, Chief Financial Officer
- Jerry (Jiawei) Wang, Chief Executive Officer
- Bob Buchanan, Vice President of Sales
Verified email and direct lines for Qualigen Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Qualigen Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Qualigen Therapeutics in the news
Companies similar to Qualigen Therapeutics
- AIM ImmunoTech · Biotechnology, Health Care, Therapeutics
- Gain Therapeutics · Biotechnology, Health Care, Therapeutics
- Brenus · Biotechnology, Health Care, Therapeutics
- STORM Therapeutics · Biotechnology, Health Care, Therapeutics
- Orasis Pharmaceuticals · Biotechnology, Health Care, Therapeutics
About Qualigen Therapeutics: questions and answers
What does Qualigen Therapeutics do?
Qualigen Therapeutics, Inc. is a small-cap company facing challenges, including the need to regain compliance with NASDAQ's continued listing requirements. The company aims to establish a new strategic direction and enhance shareholder value.
Where is Qualigen Therapeutics headquartered?
Qualigen Therapeutics is headquartered in Carlsbad, California, United States.
How many employees does Qualigen Therapeutics have?
Qualigen Therapeutics has about 32 employees.
Has Qualigen Therapeutics raised funding?
Yes. Fundz has recorded 2 funding events for Qualigen Therapeutics. The most recent, Seed of $4.5M, was in Aug 2025.
Who leads Qualigen Therapeutics?
Kevin Richardson is an Interim Ceo/cfo & Board Member at Qualigen Therapeutics.
What is the latest news on Qualigen Therapeutics?
On Nov 20, 2025, Qualigen Therapeutics, Inc. Appoints Koti Meka as Executive Director
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy